Subscribe To
Shareholder alert: the law offices of vincent wong investigate ars pharmaceuticals, inc. (spry) for potential violations of securities laws
NEW YORK, Sept. 28, 2023 (GLOBE NEWSWIRE) — Attention ARS pharmaceuticals, Inc. (“ARS”) (NASDAQ: ...
September 28, 2023, 4:46 pm
Tff pharmaceuticals to participate in upcoming investor conferences
FORT WORTH, Texas, Sept. 28, 2023 (GLOBE NEWSWIRE) -- TFF pharmaceuticals, Inc. (NASDAQ: TFFP), a clin...
September 28, 2023, 4:29 pm
Regeneron to report third quarter 2023 financial and operating results and host conference call and webcast on november 2, 2023
TARRYTOWN, N.Y., Sept. 28, 2023 (GLOBE NEWSWIRE) -- Regeneron pharmaceuticals, Inc. (NASDAQ: REGN) toda...
September 28, 2023, 4:05 pm
Onconova therapeutics to present a late-breaking abstract on rigosertib at the 2023 eadv congress
NEWTOWN, Pa., Sept. 28, 2023 (GLOBE NEWSWIRE) — Onconova Therapeutics, Inc. (NASDAQ: ONTX), (“Onconova”, the “Company”), a clinical-stage bi...
September 28, 2023, 12:00 pm
Why is synlogic (sybx) stock down 6% today?
Synlogic (NASDAQ: SYBX ) stock is sliding lower on Thursday after the biopharmaceutical company announ...
September 28, 2023, 9:13 am
Aclaris therapeutics: the many lives of this biopharmaceutical developer
Aclaris Therapeutics is a developer of kinome-based medicines for immune-inflammatory and oncology indications. The company's platform, KINect, helps ...
September 28, 2023, 7:18 am
Matinas biopharma to present at two investment conferences in october 2023
BEDMINSTER, N.J., Sept. 28, 2023 (GLOBE NEWSWIRE) -- Matinas BioPharma (NYSE American: MTNB), a clinical-stage bio...
September 28, 2023, 7:00 am
Spexis announces the appointment of gonçalo bernardes, ph.d., as acting head of chemical biology
ALLSCHWIL, Switzerland, Sept. 27, 2023 (GLOBE NEWSWIRE) — Spexis AG (SIX: SPEX), a clinical-stage biopharmac...
September 28, 2023, 5:30 am
Alert: the m&a class action firm continues investigating the merger – icpt, splk, rpt, pfsw
NEW YORK, Sept. 27, 2023 (GLOBE NEWSWIRE) — Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the �...
September 28, 2023, 12:35 am
Medicinova announces results of studies under barda contract to develop mn 166 (ibudilast) as a medical countermeasure against chlorine gas-induced lung injury
LA JOLLA, Calif., Sept. 27, 2023 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company tra...
September 27, 2023, 11:00 pm
23andme announces poster presentations on 23me-00610, an investigational antibody targeting cd200r1, at the society for immunotherapy of cancer’s (sitc) 2023 annual meeting
23andMe to present data on efficacy and safety and dose selection for the ongoing 23ME-00610 Phase 1/2a clinical trial in patients with advanced solid...
September 27, 2023, 8:05 pm
Sagimet biosciences announces completion of enrollment of 120 patients for phase 3 clinical trial by its partner ascletis of denifanstat combined with bevacizumab for treatment of recurrent glioblasto
SAN MATEO, Calif., Sept. 27, 2023 (GLOBE NEWSWIRE) — Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage bio...
September 27, 2023, 8:05 pm
Sagimet biosciences announces completion of enrollment of 120 patients for phase 3 clinical trial by its partner ascletis of denifanstat combined with bevacizumab for treatment of recurrent glioblasto
SAN MATEO, Calif., Sept. 27, 2023 (GLOBE NEWSWIRE) — Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage bio...
September 27, 2023, 8:05 pm
Acadia stock price analysis: acad risk/reward is attractive
Acadia pharmaceuticals (NASDAQ: ACAD) stock price did well on Wednesday even as American equities retre...
September 27, 2023, 5:14 pm
Enzyme stabilizer market expected to reach us$ 6.2 billion by 2033 | fact.mr report
Increasing demand for enzymes in various industries such as food and beverages, pharmaceuticals, textil...
September 27, 2023, 3:30 pm
Why shares of apellis pharmaceuticals were down wednesday
Apellis just got a J-code for reimbursement for its lead therapy from CMS. The company saw revenue climb 473% year over year in the second quarter....
September 27, 2023, 3:10 pm
Don't miss the boom: 3 pharma stocks set to explode higher
The pharmaceuticals market has taken a bit of a breather in recent weeks after an exhilarating rally ea...
September 27, 2023, 2:56 pm
Is it a good time to invest in aurinia pharmaceuticals (auph)?
Here we discuss why investing in Aurinia pharmaceuticals (AUPH) stock now may be a prudent move....
September 27, 2023, 11:18 am
Aurinia pharmaceuticals: reassessing as it gains traction
Aurinia pharmaceuticals is a biopharmaceutical company f...
September 27, 2023, 11:02 am
Wall street thinks madrigal pharmaceuticals could climb 93%. here's why it could happen soon.
Analysts have high hopes for Madrigal pharmaceuticals over the coming year. Its drug resmetirom seems e...
September 27, 2023, 9:53 am